tirzepatide phase 3 mash Pharmacological treatment for metabolic dysfunction–associated steatotic liver disease and related disorders: Current and emerging therapeutic options Lilly unveils positive results for

You want to avoid surgery and anesthesia

This helps keep your routine consistent and avoids disruption

Medication used over time in the right context and with the proper advice and team approach to cate can foster sustained change.

Patients initiating semaglutide therapy should anticipate gradual changes in appetite and eating patterns, typically beginning within the first two to four weeks of treatment

These metabolites are known to stimulate GLP-1 and PYY secretion and improve gut barrier function, processes that may enhance the metabolic efficacy of GLP-1 RA therapy when combined with dietary fiber enrichment ( The clinical relevance of such complementary approaches is highlighted by evidence showing that co-administration of probiotics, such as Limosilactobacillus fermentum GB102, with GLP-1RAs (e.g., dulaglutide) significantly enhances weight loss and attenuates weight regain after treatment cessation in obese mice ( While probiotics and prebiotics aim to reshape microbial communities and their metabolic activity, postbiotics offer an alternative strategy by directly delivering bioactive microbial products, particularly in individuals characterized by marked dysbiosis or reduced microbial diversity